[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.124.106. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Other Articles
February 27, 1937

EFFECTS OF VERY EARLY SERUM TREATMENT IN PNEUMOCOCCUS TYPE I PNEUMONIA

Author Affiliations

NEW YORK

From the New York Hospital and the Department of Medicine of the Cornell University Medical College.

JAMA. 1937;108(9):689-692. doi:10.1001/jama.1937.02780090001001
Abstract

It is a fundamental principle in all serum therapy that to obtain the best results the serum must be given early in the disease. This statement holds true regardless of whether one is using antitoxic or antibacterial serum. During the past decade there have appeared in American and British medical literature a goodly number of reports on the successful use of refined and concentrated antipneumococcus serum in the treatment of pneumococcic pneumonia. The majority of these reports have dealt with pneumococcus type I infections. More recently, however, a number of articles have appeared, reporting favorable results with serum in the treatment of other types of pneumococcic pneumonia. Promising figures have been submitted for the serum treatment of types II, V, VII, VIII and XIV. The most significant feature of these reports on serotherapy is that they are all, without exception, favorable. I cannot recall a single skeptical article since the

First Page Preview View Large
First page PDF preview
First page PDF preview
×